PDE3B Antikörper (Middle Region)
Kurzübersicht für PDE3B Antikörper (Middle Region) (ABIN954064)
Target
Alle PDE3B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 407-435, Middle Region
-
Spezifität
- This antibody recognizes Human PDE3B (Center).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 407-435 amino acids from the Central region of Human PDE3B
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PDE3B (phosphodiesterase 3B, CGMP-Inhibited (PDE3B))
-
Andere Bezeichnung
- PDE3B
-
Hintergrund
- Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes, PDE3B may play a role in fat metabolism.Synonyms: 5'-cyclic phosphodiesterase B, CGI-PDE B, CGIP, CGIP1, CGIPDE1, Cyclic GMP-inhibited phosphodiesterase B, HcGIP1, Phosphodiesterase 3B, Phosphodiesterase-3B cGMP-inhibited, cGMP-inhibited 3'
-
Molekulargewicht
- 124333 Da
-
Gen-ID
- 5140
-
NCBI Accession
- NP_000913
-
Pathways
- Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process
Target
-